Analysed TIVIC HEALTH SYSTEMS INC (TIVC:NASDAQ) News Sources
Tivic Health Selected to Present Entolimodâ„¢ as a Radiation Countermeasure and its Plans for an Oral Transmucosal Program to the Department of War Tech Watch Program on May 7th
15-04-2026
yahoo.com
Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod
31-03-2026
yahoo.com
Presenting on Emerging Growth Conference 91 Day 1 on April 1; Register to live stream
31-03-2026
yahoo.com
Tivic CEO To Present at the Upcoming Emerging Growth's April 2026 Virtual Conference
27-03-2026
yahoo.com
Tivic Secures NIAID Non-Clinical Evaluation Agreement for Entolimod, Targeting Gastrointestinal Acute Radiation Syndrome
26-03-2026
yahoo.com
Tivic To Report 2025 Year-End Financial Results Via Conference Call and Webcast on March 25th at 1:30pm PT / 4:30pm ET
20-03-2026
yahoo.com
Biotech Veteran Michael K. Handley Named CEO of Tivic Health Systems to Spearhead Strategic Expansion in Biopharma
04-03-2026
yahoo.com
What is the current price of TIVIC HEALTH SYSTEMS INC (TIVC:NASDAQ)?
The current price of TIVIC HEALTH SYSTEMS INC (TIVC:NASDAQ) is $1.27.
TIVIC HEALTH SYSTEMS INC (TIVC:NASDAQ) absolute price change since previous trading day?
The absolute price change of TIVIC HEALTH SYSTEMS INC (TIVC:NASDAQ) since the previous trading day is $0.14.
TIVIC HEALTH SYSTEMS INC (TIVC:NASDAQ) percentage price change since previous trading day?
The percentage price change of TIVIC HEALTH SYSTEMS INC (TIVC:NASDAQ) since the previous trading day is 12.3894%.
What is the most recent average sentiment score for TIVIC HEALTH SYSTEMS INC (TIVC:NASDAQ)?
The most recent average sentiment score for TIVIC HEALTH SYSTEMS INC (TIVC:NASDAQ) is 79 out of 100.
What is the most recent average sentiment for TIVIC HEALTH SYSTEMS INC (TIVC:NASDAQ)?
The most recent sentiment for TIVIC HEALTH SYSTEMS INC (TIVC:NASDAQ) is .
SEC-8K** Filing Available For TIVIC HEALTH SYSTEMS INC (TIVC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.